Your Partners in Unlocking New Possibilities. Meet Our Leadership Team at CPHI Frankfurt at Booth No. 5.0C84.
Book a Meeting
Your Partners in Unlocking New Possibilities. Meet Our Leadership Team at CPHI Frankfurt at Booth No. 5.0C84.
Book a Meeting
Oct 01, 2025
.png "peptide synthesis and manufacturing")
Peptides are short chains of amino acids that play a natural role in many biological processes. In recent years, they have become an increasingly important class of therapeutics due to their specificity, versatility, and low toxicity. As a result, peptide APIs are now at the center of modern drug discovery and development.
Peptides are gaining attention across various therapeutic areas, including oncology and metabolic disorders. Their ability to selectively interact with biological targets makes them an attractive alternative to traditional small molecules. Advances in synthetic chemistry, API manufacturing, and formulation have further expanded the potential of peptide-based drugs, supporting the steady growth of peptide-based drug pipelines.
The journey of peptide therapeutics begins in the drug discovery stage, where researchers identify promising sequences and evaluate their stability, efficacy, and safety. Once a lead candidate is selected, the process moves into synthesis, where amino acids are sequentially added to create the peptide chain.
After synthesis, purification and characterization techniques - such as chromatography - are employed to achieve the required purity levels. Analytical methods then confirm the identity and consistency of the peptide. Before manufacturing the peptide on a large scale, processes must be optimized for yield, reproducibility, and compliance. This stage often involves handling of HPAPIs and specialized containment to ensure safety and quality.
Following these steps, the peptide is ready for final production. This is when peptides are formulated, packaged, and prepared for use in clinical trials or commercial distribution, completing the journey from concept to medicine.
With more than 40 years of peptide experience and a dedicated peptide facility, Piramal Pharma Solutions offers end-to-end capabilities in peptide synthesis and manufacturing. This includes research and development, custom synthesis, and clinical and commercial manufacturing. We also offer a portfolio of generic peptide APIs, ranging from multigram to kilogram scale.
Relying on our extensive expertise and an unwavering commitment to Patient Centricity, we ensure continuity, quality, and compliance at every step. We also boast the capacity to integrate our peptide API with our formulation and/or commercial manufacturing solutions, streamlining development timelines and accelerating treatments to patients in need.
Peptides represent one of the most exciting frontiers in modern drug development. Their precision, adaptability, and therapeutic potential make them a vital part of the future pharma landscape. With decades of experience, specialized facilities, and a commitment to partnership, Piramal Pharma Solutions is uniquely positioned to support the journey of peptide APIs - from discovery to commercialization - helping bring these advanced therapies to patients worldwide.
